GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » EV-to-FCF

Shandong Boan Biotechnology Co (HKSE:06955) EV-to-FCF : -15.80 (As of May. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shandong Boan Biotechnology Co's Enterprise Value is HK$5,415.4 Mil. Shandong Boan Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-342.7 Mil. Therefore, Shandong Boan Biotechnology Co's EV-to-FCF for today is -15.80.

The historical rank and industry rank for Shandong Boan Biotechnology Co's EV-to-FCF or its related term are showing as below:

HKSE:06955' s EV-to-FCF Range Over the Past 10 Years
Min: -23.14   Med: -17.12   Max: -13.42
Current: -15.8

During the past 4 years, the highest EV-to-FCF of Shandong Boan Biotechnology Co was -13.42. The lowest was -23.14. And the median was -17.12.

HKSE:06955's EV-to-FCF is ranked worse than
100% of 390 companies
in the Biotechnology industry
Industry Median: 6.365 vs HKSE:06955: -15.80

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Shandong Boan Biotechnology Co's stock price is HK$10.20. Shandong Boan Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.257. Therefore, Shandong Boan Biotechnology Co's PE Ratio for today is At Loss.


Shandong Boan Biotechnology Co EV-to-FCF Historical Data

The historical data trend for Shandong Boan Biotechnology Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co EV-to-FCF Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - -22.29 -23.68

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial - - -22.29 - -23.68

Competitive Comparison of Shandong Boan Biotechnology Co's EV-to-FCF

For the Biotechnology subindustry, Shandong Boan Biotechnology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Boan Biotechnology Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shandong Boan Biotechnology Co's EV-to-FCF falls into.



Shandong Boan Biotechnology Co EV-to-FCF Calculation

Shandong Boan Biotechnology Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5415.378/-342.711
=-15.80

Shandong Boan Biotechnology Co's current Enterprise Value is HK$5,415.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shandong Boan Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-342.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Boan Biotechnology Co  (HKSE:06955) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shandong Boan Biotechnology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10.20/-0.257
=At Loss

Shandong Boan Biotechnology Co's share price for today is HK$10.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shandong Boan Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.257.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shandong Boan Biotechnology Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines